Beside suppression of cell proliferation and inducing cell apoptosis, exploiting anti-nrf2 siRNAs conjugated NPs significantly enhanced CLL cell sensitivity to damage, based on the reduced IC50 and IC80. Here, NFE2L2 is linked to B-cell chronic lymphocytic leukemia.